Occupational Asthma Reference

Henry, Travis S., Kanne, Jeffrey P., Kligerman, Seth J., Imaging of Vaping-Associated Lung Disease, New England Journal of Medicine, 2019;381:1486-1487,10.1056/NEJMc1911995 [doi]

Keywords: usa, vaping, CT, radiology

Known Authors

If you would like to become a known author and have your picture displayed along with your papers then please get in touch from the contact page. Known authors can choose to receive emails when their papers receive comments.

Abstract

Lung injury associated with vaping — the use of electronic nicotine delivery systems (ENDS) — has been recognized in the medical literature,1,2 and a case series of such injuries is now published in the Journal.3 If vaping is the proximal cause of lung injury, the mechanism leading to such injury is not certain. Unlike traditional cigarettes, ENDS use solvents to heat and aerosolize the flavorants (known as “juices”),4 which consist of various aldehydes and alcohols, and complications can arise as the mixing and aerosolization of these components create new compounds. Moreover, ENDS are increasingly used to deliver cannabis oils and concentrates.

We have collectively seen 19 cases and reviewed the literature regarding another 15 cases. All met the case definition of vaping-associated lung injury, which includes “abnormalities on chest imaging.” We identified four imaging patterns that correlated with pathological findings attributable to vaping, including acute eosinophilic pneumonia, diffuse alveolar damage, organizing pneumonia, and lipoid pneumonia. In addition, some cases were associated with variegated imaging patterns. Through clinical and pathological investigations, patterns of giant-cell interstitial pneumonia, hypersensitivity pneumonitis, and diffuse alveolar hemorrhage were identified.
Although the variety of imaging patterns suggests different mechanisms of injury, and more patterns will probably be reported, most of the patterns have basilar-predominant consolidation and ground-glass opacity, often with areas of lobular or subpleural sparing. Rapidly developing acute lung injuries (e.g., acute eosinophilic pneumonia and diffuse alveolar damage) are associated with inhalational injuries and have overlapping pathological and imaging findings,5 and they have been reported to occur with vaping.1 Hypersensitivity pneumonitis is an immune response to an environmental antigen, but the antigens related to vaping are unknown. Lipoid pneumonia is an inflammatory response to the presence of lipids within the alveolar space and typically results from aspiration of hydrocarbons or oil-based products, but it has now been seen with vaping. We have not observed the computed tomographic finding of fat attenuation in the lung, which is a hallmark of lipoid pneumonia, in these cases of vaping-associated lung injury. Not all cases are acute; organizing pneumonia often develops subacutely, over a period of days to weeks, and the one case of giant-cell interstitial pneumonia (a rare fibrosing interstitial lung disease) that was correlated with hard metals in ENDS developed over a period of 6 months.

Plain text: Lung injury associated with vaping - the use of electronic nicotine delivery systems (ENDS) - has been recognized in the medical literature,1,2 and a case series of such injuries is now published in the Journal.3 If vaping is the proximal cause of lung injury, the mechanism leading to such injury is not certain. Unlike traditional cigarettes, ENDS use solvents to heat and aerosolize the flavorants (known as "juices"),4 which consist of various aldehydes and alcohols, and complications can arise as the mixing and aerosolization of these components create new compounds. Moreover, ENDS are increasingly used to deliver cannabis oils and concentrates. We have collectively seen 19 cases and reviewed the literature regarding another 15 cases. All met the case definition of vaping-associated lung injury, which includes "abnormalities on chest imaging." We identified four imaging patterns that correlated with pathological findings attributable to vaping, including acute eosinophilic pneumonia, diffuse alveolar damage, organizing pneumonia, and lipoid pneumonia. In addition, some cases were associated with variegated imaging patterns. Through clinical and pathological investigations, patterns of giant-cell interstitial pneumonia, hypersensitivity pneumonitis, and diffuse alveolar hemorrhage were identified. Although the variety of imaging patterns suggests different mechanisms of injury, and more patterns will probably be reported, most of the patterns have basilar-predominant consolidation and ground-glass opacity, often with areas of lobular or subpleural sparing. Rapidly developing acute lung injuries (e.g., acute eosinophilic pneumonia and diffuse alveolar damage) are associated with inhalational injuries and have overlapping pathological and imaging findings,5 and they have been reported to occur with vaping.1 Hypersensitivity pneumonitis is an immune response to an environmental antigen, but the antigens related to vaping are unknown. Lipoid pneumonia is an inflammatory response to the presence of lipids within the alveolar space and typically results from aspiration of hydrocarbons or oil-based products, but it has now been seen with vaping. We have not observed the computed tomographic finding of fat attenuation in the lung, which is a hallmark of lipoid pneumonia, in these cases of vaping-associated lung injury. Not all cases are acute; organizing pneumonia often develops subacutely, over a period of days to weeks, and the one case of giant-cell interstitial pneumonia (a rare fibrosing interstitial lung disease) that was correlated with hard metals in ENDS developed over a period of 6 months.

Full Text

Full text of this reference not available

Please Log In or Register to add the full text to this reference

Associated Questions

There are no associations for this paper.

Please Log In or Register to put forward this reference as evidence to a question.

Comments

Please sign in or register to add your thoughts.


Oasys and occupational asthma smoke logo